Infant LRTIs Nearly Double Risk of Premature Death in Adulthood
Contracting a lower respiratory tract infection before age 2 may increase the risk of dying prematurely in adulthood from a respiratory disease.
Contracting a lower respiratory tract infection before age 2 may increase the risk of dying prematurely in adulthood from a respiratory disease.
In the second in series of updates on guidance for infection control in acute-care hospitals, five medical organizations are recommending best practices for preventing hospital-associated pneumonia.
Children who came down with pneumonia during infancy have a higher risk for asthma later in life.
Recent data shows that 14.5% of the deaths during the week ending January 2 were due to pneumonia, influenza, and COVID-19.
Read MoreOne year ago, on Dec 30, 2019, the first media reports were published about a mysterious viral pneumonia spreading through Wuhan, China.
Read MoreCOVID-19 has forced many severely ill patients to undergo mechanical ventilation for extended durations, an intervention that can increase their risks of other hospital-acquired infections such as ventilator-associated pneumonia (VAP).
Read MoreA total of 232 buildings and monuments from 48 different countries will be illuminated in blue between 9:00 p/m and 10:00 p/m on November 12 in recognition of World Pneumonia Day.
Read MoreBeyond Air Inc will initiate a clinical study of its LungFit tankless nitric oxide (NO) system for evaluation of the safety and efficacy of high concentration inhaled NO given intermittently to adults hospitalized with acute viral pneumonia, including SARS-CoV-2.
Read MoreBroader use of the pneumococcal and Hib vaccines could guard against the worst effects of a COVID-19 illness, according to a report from The Conversation.
Read MoreAt least one preventive dental visit within three years of a patient being placed on a mechanical ventilator reduced the likelihood of a VAP diagnosis by 22%.
Read MorePeople who had bronchitis at least once before the age of seven are more likely to develop lung problems in later life, according to research presented at the virtual ERS 2020.
Read MoreA team of researchers showed that artificial intelligence could help predict the type of bacteria that caused infection in patients with pneumonia.
Read MoreA report from STAT News examines how the novel coronavirus pandemic can bring awareness to how providers diagnose other infections.
Read MoreThe FDA has approved Recarbrio (combination imipenem-cilastatin and relebactam) to treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia.
Read MoreElderly patients who are hospitalized with pneumonia are twice as likely to die as those hospitalized with hip fractures, yet many elderly people fail to accurately assess their risk of pneumonia, concludes research which will be presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID).
Read More